We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

165 hedge funds and large institutions have $733M invested in Spectrum Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 27 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 27

5% less funds holding

Funds holding: 173 → 165 (-8)

17% less capital invested

Capital invested by funds: $881M → $733M (-$147M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

97% less call options, than puts

Call options by funds: $342K | Put options by funds: $13.6M

Holders
165
Holders Change
-8
Holders Change %
-4.62%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
82
Reduced
27
Closed
23
Calls
$342K
Puts
$13.6M
Net Calls
-$13.2M
Net Calls Change
-$12.3M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$9.25M
2
N
Nuveen
North Carolina
+$6.99M
3
BlackRock
BlackRock
New York
+$6.96M
4
Morgan Stanley
Morgan Stanley
New York
+$5.66M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$20.6M
2
Millennium Management
Millennium Management
New York
-$9.17M
3
Bank of America
Bank of America
North Carolina
-$3.03M
4
State Street
State Street
Massachusetts
-$2.83M
5
Invesco
Invesco
Georgia
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWM
126
Mission Wealth Management
California
$86K – – –
NFC
127
Northeast Financial Consultants
Connecticut
$86K – – –
AIP
128
Ameritas Investment Partners
Nebraska
$82K +$9.71K +1,085 +13%
QT
129
Quantamental Technologies
New York
$82K +$15.7K +1,757 +23%
LIA
130
LS Investment Advisors
Michigan
$60K – – –
Zurich Cantonal Bank
131
Zurich Cantonal Bank
Switzerland
$46K – – –
UBS Group
132
UBS Group
Switzerland
$44K -$4.42K -494 -9%
FMT
133
First Mercantile Trust
Tennessee
$43K -$224 -25 -0.5%
PMFA
134
Plante Moran Financial Advisors
Michigan
$36K – – –
FWM
135
Focused Wealth Management
New York
$34K – – –
TPWA
136
TRUE Private Wealth Advisors
Oregon
$34K +$35.8K +4,000 New
MOACM
137
Mutual of America Capital Management
New York
$33K +$7.17K +801 +27%
SGAM
138
Smith Group Asset Management
Texas
$28K – – –
TRCT
139
Tower Research Capital (TRC)
New York
$24K +$22.9K +2,565 +1,283%
SWA
140
Sutton Wealth Advisors
Florida
$23.1K – – –
Royal Bank of Canada
141
Royal Bank of Canada
Ontario, Canada
$20K -$41K -4,583 -66%
PA
142
Parallel Advisors
California
$20K – – –
ONST
143
Old North State Trust
North Carolina
$12K – – –
Daiwa Securities Group
144
Daiwa Securities Group
Japan
$6K – – –
FHA
145
Flagship Harbor Advisors
Massachusetts
$5K – – –
Federated Hermes
146
Federated Hermes
Pennsylvania
$5K +$5.36K +599 New
FDCDDQ
147
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.3K – – –
Nisa Investment Advisors
148
Nisa Investment Advisors
Missouri
$4K – – –
FPFS
149
First Personal Financial Services
North Carolina
$3K – – –
US Bancorp
150
US Bancorp
Minnesota
$3K +$1.57K +176 +144%
4 5
6
7 8

SPPI Hedge Fund Activity: Q2 2019 in Review

165 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2019, worth a combined $733M — down 17% from $881M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 17 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 82 added.

The largest buyer was Renaissance Technologies, adding an estimated $9.25M. The largest seller was Armistice Capital, exiting entirely with an estimated $20.6M sold.

  • 165 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2019, down from 173 in Q1 2019.
  • Funds reported $733M of Spectrum Pharmaceuticals Inc stock for Q2 2019, down 17% quarter-over-quarter.
  • 17 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of -6 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2019 was Renaissance Technologies, an estimated $9.25M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2019 was Armistice Capital, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2019.